265 related articles for article (PubMed ID: 15962096)
1. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.
Kiss L; Szabó C
Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():29-37. PubMed ID: 15962096
[TBL] [Abstract][Full Text] [Related]
2. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.
Pacher P; Szabó C
Antioxid Redox Signal; 2005; 7(11-12):1568-80. PubMed ID: 16356120
[TBL] [Abstract][Full Text] [Related]
3. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.
Ceriello A
Diabetes Care; 2003 May; 26(5):1589-96. PubMed ID: 12716823
[TBL] [Abstract][Full Text] [Related]
4. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
Pacher P; Obrosova IG; Mabley JG; Szabó C
Curr Med Chem; 2005; 12(3):267-75. PubMed ID: 15723618
[TBL] [Abstract][Full Text] [Related]
5. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction.
Mabley JG; Soriano FG
Curr Vasc Pharmacol; 2005 Jul; 3(3):247-52. PubMed ID: 16026321
[TBL] [Abstract][Full Text] [Related]
6. Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.
Obrosova IG; Julius UA
Curr Vasc Pharmacol; 2005 Jul; 3(3):267-83. PubMed ID: 16026323
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.
Du X; Matsumura T; Edelstein D; Rossetti L; Zsengellér Z; Szabó C; Brownlee M
J Clin Invest; 2003 Oct; 112(7):1049-57. PubMed ID: 14523042
[TBL] [Abstract][Full Text] [Related]
9. Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions.
Islam BU; Habib S; Ali SA; Moinuddin ; Ali A
Cardiovasc Toxicol; 2017 Oct; 17(4):373-383. PubMed ID: 27990620
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
[TBL] [Abstract][Full Text] [Related]
11. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury.
Szabó G; Bährle S
Curr Vasc Pharmacol; 2005 Jul; 3(3):215-20. PubMed ID: 16026318
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase activation by reactive nitrogen species--relevance for the pathogenesis of inflammation.
Szabó C
Nitric Oxide; 2006 Mar; 14(2):169-79. PubMed ID: 16111903
[TBL] [Abstract][Full Text] [Related]
13. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.
Obrosova IG; Drel VR; Pacher P; Ilnytska O; Wang ZQ; Stevens MJ; Yorek MA
Diabetes; 2005 Dec; 54(12):3435-41. PubMed ID: 16306359
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in understanding the role of oxidative stress in diabetic neuropathy.
Shakeel M
Diabetes Metab Syndr; 2015; 9(4):373-8. PubMed ID: 25470637
[TBL] [Abstract][Full Text] [Related]
15. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
[TBL] [Abstract][Full Text] [Related]
16. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.
Soriano FG; Virág L; Szabó C
J Mol Med (Berl); 2001 Aug; 79(8):437-48. PubMed ID: 11511974
[TBL] [Abstract][Full Text] [Related]
17. Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications.
Szabó C
Pharmacol Res; 2005 Jul; 52(1):60-71. PubMed ID: 15911334
[TBL] [Abstract][Full Text] [Related]
18. Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in the pathogenesis of liver injury.
Gero D; Szabó C
Curr Pharm Des; 2006; 12(23):2903-10. PubMed ID: 16918420
[TBL] [Abstract][Full Text] [Related]
19. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.
Pacher P; Szabo C
Am J Pathol; 2008 Jul; 173(1):2-13. PubMed ID: 18535182
[TBL] [Abstract][Full Text] [Related]
20. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
Pacher P; Szabó C
Cardiovasc Drug Rev; 2007; 25(3):235-60. PubMed ID: 17919258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
